Global X Genomics & Biotechnology ETF
Filed by Global X Funds. What this fund reported holding in its latest quarterly NPORT-P. Positions are ordered by share of the fund rather than by size, because that is what separates a conviction from a rounding error.
What it holds
Largest share of the fund first.
| Company | % of fund | Value |
|---|---|---|
| MRNAModerna Inc | 7.50% | $6.9M |
| TWSTTwist Bioscience Corp | 6.34% | $5.8M |
| GHGuardant Health Inc | 5.28% | $4.8M |
| ILMNIllumina Inc | 4.87% | $4.5M |
| NTRANatera Inc | 4.60% | $4.2M |
| VRTXVertex Pharmaceuticals Inc | 3.70% | $3.4M |
| TECHBio-Techne Corp | 3.67% | $3.4M |
| BMRNBioMarin Pharmaceutical Inc | 3.58% | $3.3M |
| ARWRArrowhead Pharmaceuticals Inc | 3.31% | $3M |
| PRAXPraxis Precision Medicines Inc | 3.09% | $2.8M |
| BNTXBiontech SE | 2.78% | $2.6M |
| VCYTVeracyte Inc | 2.61% | $2.4M |
| LLYEli Lilly and Co | 1.86% | $1.7M |
| RAREUltragenyx Pharmaceutical Inc | 1.82% | $1.7M |
| CDNACareDx Inc | 1.78% | $1.6M |
| GILDGilead Sciences, Inc | 1.64% | $1.5M |
| SRPTSarepta Therapeutics Inc | 1.63% | $1.5M |
| NTLAIntellia Therapeutics Inc | 1.11% | $1M |
| DHRDanaher Corp | 1.05% | $967.6K |
| BMYBristol-Myers Squibb Co | 1.04% | $954.5K |
| MRVIMaravai LifeSciences Holdings Inc | 0.62% | $572.6K |
| AAgilent Technologies Inc | 0.33% | $303.7K |
| BRKRBruker Corp | 0.33% | $299.5K |
| DGXQuest Diagnostics Inc | 0.26% | $241.3K |
| EDITEditas Medicine Inc | 0.23% | $213.4K |
Source: NPORT-P filings, via EDGAR. Positions arrive by CUSIP, and only a CUSIP verified against a ticker is kept — so this is what we could match, not everything the fund holds, and the matched value is therefore below the fund's own size. A balance is shares where the filing says `NS` and a principal amount where it says `PA`, which is why it is not labelled shares in both cases.
Follow Global X Genomics & Biotechnology ETF by email
Global X Genomics & Biotechnology ETF's new holdings reports, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.